Caxton Associates (New York)’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,775
Closed -$677K 570
2022
Q2
$677K Buy
+3,775
New +$964K 0.07% 199
2021
Q4
Sell
-1,417
Closed -$559K 612
2021
Q3
$559K Buy
+1,417
New +$652K 0.06% 184
2021
Q2
Sell
-1,087
Closed -$406K 533
2021
Q1
$406K Buy
+1,087
New +$443K 0.04% 199
2019
Q1
Sell
-819
Closed -$239K 438
2018
Q4
$239K Buy
+819
New +$254K 0.04% 223
2017
Q3
Sell
-1,850
Closed -$312K 553
2017
Q2
$312K Buy
+1,850
New +$320K 0.01% 437

Other funds holding ILMN

Caxton Associates (New York)'s ILMN Position: Q3 2022 in Review

Caxton Associates (New York) sold out of Illumina (ILMN) in Q3 2022, closing a stake of 3,775 shares — an estimated $677K sold.

Caxton Associates (New York) first reported a position in ILMN in Q2 2017 and held it in 5 quarters. The position peaked at $677K in Q2 2022. 897 funds tracked by Wall St. Rank hold ILMN as of Q3 2022.

  • Caxton Associates (New York) reported no remaining Illumina position as of Q3 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,775 Illumina shares in Q3 2022, an estimated $677K.
  • Caxton Associates (New York) first reported a position in Illumina in Q2 2017 and held it in 5 quarters.
  • Caxton Associates (New York)'s Illumina position peaked at $677K in Q2 2022.
  • 897 funds tracked by Wall St. Rank held Illumina as of Q3 2022.

Based on Caxton Associates (New York)'s 13F filing for Q3 2022, filed 14 Nov 2022.